We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Apple Tree Partners (ATP) will exit its ownership stake in Corvidia Therapeutics, a precision cardiovascular therapeutics company, with Novo Nordisk’s acquisition of Corvidia.